跳至主要内容
临床试验/NCT05426980
NCT05426980已完成不适用

Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study

University of Ljubljana4 个研究点 分布在 1 个国家目标入组 654 人开始时间: 2021年12月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
654
试验地点
4
主要终点
Atrophied lesion volume derived from MRI predicts confirmed EDSS disability progression

研究概览

简要总结

The study proposal focuses on multiple sclerosis (MS), a chronic incurable disease of the central nervous system (CNS). The MS disease is characterised by recurrent transient disability progression, quantified by increase in the extended disability status score (EDSS), and subsequent remission (disappearance of symptoms and reduced EDSS score) or, alternatively, a gradual EDSS disability progression and exacerbation of associated symptoms. At the same time, the MS is characterised by multifocal inflammatory lesions disseminated throughout the white and grey matter of the CNS, which can be observed and quantified in the magnetic resonance (MR) scans. The proposed study will address the critical unmet need of computer-assisted extraction and assessment of prognostic factors based from an individual patient's brain MR scan, such as lesion count, volume, whole-brain and regional brain atrophy, and atrophied lesion volume, in order to evaluate the capability for personalized future disability progression prediction.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •persons diagnosed with MS (any phenotype; according to the 2010 McDonald criteria) and CIS patients
  • •availability of at least two MRI exams with both FLAIR and T1-weighted scans of the same participant over a period of at least 6 months at the most recent examination
  • •availability of demographic, clinical data and treatment information for the same participant over a period of at least 6 months at the most recent examination
  • •availability of EDSS score and at least one previous EDSS scores for the same participant over a period of at least 6 months at the most recent examination

排除标准

  • •other clinically relevant systemic diseases if the researcher considers them to be significant

结局指标

主要结局

Atrophied lesion volume derived from MRI predicts confirmed EDSS disability progression

时间窗: Atrophied lesion volume quantified from two or more MR scans across the span of at least one and up to five years

Patients will be divided into two groups based on the presence or absence of EDSS disability progression (DP) during the observation period. The DP converters will be classified as patients with an EDSS change of at least 1.5 if the baseline EDSS is less than 1.0, those with an EDSS change of at least 1.0 if the baseline EDSS is 1.0-5.5, and those with an EDSS change of at least 0.5 if the baseline EDSS is 5.5 or higher \[15\]. DP converters should have confirmed progression of EDSS impairment over a period of at least 6 months. DP non-converters include individuals who do not meet the criteria for conversion. Atrophied lesion volume will be quantified from MR scans taken \>6 months prior to the observed EDSS increase. Advanced artificial intelligence based image analysis tools will be applied to assess the atrophied lesion volume.

次要结局

  • Atrophied lesion volume derived from MRI predicts conversion to secondary progressive multiple sclerosis(Atrophied lesion volume quantified from two or more MR scans across the span of least one and up to five years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ziga Spiclin

Associate professor, PhD

University of Ljubljana

研究点 (4)

Loading locations...

相似试验